Because of this high risk of breast cancer, women with a mutation in either the BRCA1 or BRCA2 gene are offered breast cancer surveillance, which includes annual clinical breast examination, annual mammography and annual contrast enhanced magnetic resonance imaging (MRI) of the breast [4-6]. This evidence concerns the gene BRCA1 and breast cancer.